| Company Name |
Market Cap |
TEV |
TEV/LTM Total Rev |
TEV/LTM EBITDA |
TEV/LTM EBIT |
P/Diluted EPS Before Extra |
P/TangBV |
| Acorda Therapeutics, Inc. |
1,072 |
918 |
21.5x |
- |
- |
- |
9.8x |
| Affymax, Inc. |
300 |
152 |
2.8x |
- |
- |
- |
4.2x |
| Affymetrix Inc. |
547 |
394 |
.9x |
2.7x |
3.6x |
11.9x |
1.2x |
| Akzo Nobel NV |
9,685 |
13,733 |
1.2x |
10.7x |
15.2x |
32.x |
3.1x |
| Alexion Pharmaceuticals, Inc. |
3,602 |
3,715 |
23.1x |
- |
- |
- |
46.1x |
| Altus Pharmaceuticals Inc. |
146 |
40 |
1.3x |
- |
- |
- |
1.5x |
| Amgen Inc. |
66,200 |
68,892 |
4.7x |
10.9x |
13.5x |
21.9x |
16.5x |
| Amylin Pharmaceuticals Inc. |
4,325 |
4,318 |
5.2x |
- |
- |
- |
8.6x |
| Angiotech Pharmaceuticals Inc. |
168 |
680 |
2.3x |
42.5x |
- |
- |
- |
| Applied Biosystems Inc. |
6,237 |
5,997 |
2.7x |
12.1x |
14.3x |
20.8x |
6.x |
| AstraZeneca plc |
35,870 |
47,769 |
1.6x |
4.3x |
5.3x |
6.6x |
- |
| Baxter International Inc. |
43,064 |
44,151 |
3.7x |
14.2x |
17.7x |
24.x |
5.9x |
| Bayer AG |
42,314 |
53,509 |
1.6x |
8.x |
12.9x |
18.2x |
- |
| Biogen Idec Inc. |
20,248 |
20,597 |
5.7x |
14.3x |
20.1x |
30.x |
9.9x |
| Biotest AG |
686 |
869 |
2.4x |
14.x |
20.x |
36.7x |
4.5x |
| Biovitrum AB |
2,760 |
2,024 |
1.8x |
26.8x |
153.5x |
86.3x |
2.9x |
| Cangene Corp. |
330 |
332 |
2.6x |
9.6x |
14.8x |
25.6x |
1.8x |
| Celgene Corporation |
32,904 |
31,074 |
17.3x |
57.7x |
63.8x |
- |
16.7x |
| Cephalon Inc. |
4,956 |
5,309 |
2.9x |
10.9x |
16.4x |
- |
27.3x |
| CSL Ltd. |
19,044 |
19,475 |
5.7x |
18.7x |
21.8x |
30.3x |
11.5x |
| Cubist Pharmaceuticals Inc. |
1,279 |
1,225 |
3.4x |
19.4x |
22.3x |
30.x |
10.8x |
| deCODE genetics Inc. |
99 |
298 |
6.4x |
- |
- |
- |
- |
| Elan Corp. plc |
9,504 |
10,662 |
12.5x |
- |
- |
- |
- |
| Encysive Pharmaceuticals Inc. |
190 |
364 |
8.x |
- |
- |
- |
- |
| Enzon Pharmaceuticals Inc. |
365 |
524 |
2.7x |
16.7x |
37.5x |
6.1x |
- |
| Genentech Inc. |
100,097 |
98,067 |
8.1x |
18.9x |
21.1x |
33.x |
9.4x |
| Genzyme Corp. |
20,490 |
19,235 |
4.5x |
17.x |
24.8x |
47.1x |
5.6x |
| Gilead Sciences Inc. |
49,795 |
48,480 |
10.3x |
20.2x |
20.7x |
30.x |
13.2x |
| Grifols, S.A. |
4,067 |
4,425 |
6.3x |
24.9x |
30.2x |
46.6x |
20.3x |
| Guangzhou Pharmaceutical Co. Ltd. |
3,892 |
4,042 |
.3x |
7.1x |
9.1x |
10.5x |
1.3x |
| Harvard Bioscience Inc. |
154 |
144 |
1.7x |
11.1x |
14.9x |
21.6x |
4.2x |
| Imclone Systems Inc. |
5,533 |
5,197 |
8.3x |
26.5x |
31.8x |
- |
6.7x |
| Invitrogen Corp. |
3,968 |
4,473 |
3.3x |
12.2x |
17.9x |
23.8x |
- |
| Lonza Group AG |
7,259 |
8,680 |
2.9x |
12.3x |
19.9x |
18.8x |
4.x |
| Myriad Genetics Inc. |
2,968 |
2,764 |
13.x |
- |
- |
- |
8.4x |
| Nektar Therapeutics |
460 |
386 |
1.9x |
- |
- |
- |
4.8x |
| Novo Nordisk A/S |
189,760 |
183,916 |
4.3x |
14.8x |
17.8x |
21.5x |
6.2x |
| OSI Pharmaceuticals Inc. |
3,010 |
3,026 |
8.2x |
20.9x |
22.2x |
26.x |
50.9x |
| Pfizer Inc. |
126,306 |
114,959 |
2.4x |
5.6x |
7.6x |
14.x |
4.9x |
| QLT Inc. |
276 |
328 |
2.9x |
- |
- |
- |
2.5x |
| Regeneron Pharmaceuticals Inc. |
1,732 |
1,188 |
7.2x |
- |
- |
- |
3.8x |
| Roche Holding AG |
167,596 |
165,040 |
3.5x |
10.2x |
12.1x |
17.4x |
6.3x |
| SIRTeX Medical Ltd. |
139 |
130 |
3.4x |
11.x |
11.4x |
80.4x |
6.8x |
| SkyePharma plc |
25 |
123 |
2.9x |
- |
- |
- |
- |
| Vertex Pharmaceuticals Inc. |
4,850 |
4,407 |
25.6x |
- |
- |
- |
15.9x |
| Wyeth |
54,027 |
52,944 |
2.3x |
7.1x |
8.1x |
12.3x |
3.7x |
| ZymoGenetics, Inc. |
591 |
503 |
10.7x |
- |
- |
- |
7.5x |
| |
High |
25.6x |
57.7x |
153.5x |
86.3x |
50.9x |
| |
Low |
.3x |
2.7x |
3.6x |
6.1x |
1.2x |
| |
Mean |
5.9x |
16.x |
23.3x |
28.x |
9.9x |
| |
Median |
3.4x |
13.1x |
17.8x |
23.9x |
6.3x |
